Pay in 4 interest-free payments of $6.02 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
588,168 adults with type 2 diabetes: 139,546 started a GLP-1 drug 448,622 started an SGLT2 inhibitor Followed for up to 3 yearsAt 3 years, NAION was more frequent among people who started GLP-1 drugs: GLP-1 drugs: 39.1 cases per 10,000 persons SGLT2 inhibitors: 29.3 cases per 10,000 persons That works out to 6 to 10 extra cases per 10,000
Whether its oral semaglutide or other evidence-based therapies, every recommendation is grounded in science and clinical experience
Seek medical attention if you have concerns about your health
I get to create that generational knowledge with my daughter and save her from having to be on a GLP-1 later, because she has had the opportunity to learn to eat the right things from the beginning
